The abstract is read at the publisher; the summary is JClub's.
Elevated GDF15 is significantly associated with major depressive disorder and insulin resistance, and in MDD baseline GDF15 predicts persistence of depressive symptoms over time.
- Why it matters: Major depressive disorder is linked to insulin resistance, which relates to greater risk, chronicity, and poorer treatment response, but the stress-energy signaling bridge is unclear.
- What they did: In a preregistered secondary analysis of 190 participants with MDD and 183 controls, log-transformed GDF15 was modeled against diagnosis, insulin resistance, symptoms, childhood trauma, perceived stress, and later symptom persistence; depression severity–GDF15 links were validated in an independent medication-free MDD cohort (N=168).
- The result: Across all participants, higher GDF15 correlated with greater depression severity, childhood trauma, and perceived stress, while stratified effects for severity and perceived stress appeared only in healthy controls; in MDD, baseline GDF15 was associated with symptom persistence, and in the second medication-free sample depression severity was significantly associated with GDF15.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.